Questions to bring to your clinician: Ask about expected weight-loss trajectory, monitoring plans for blood glucose and lipids, how side effects will be managed, and how tirzepatide compares with other options in your specific health context
Managing Director of DermaTouch RN, Anthony Moschitto, shares the following about the different treatments: GLP-1 agonists (Mounjarno or Tirzepatide, Ozempic/Wygovy or Semaglutide) have been clinically proven to help patients lose as much as 15% of their body weight by slowing the digestive process (stomach emptying) and improving insulin and glycogen levels
Is there an association between dipeptidyl peptidase-4 inhibitors and autoimmune disease
A method for chronic weight management in a subject in need thereof comprising administering tirzepatide, or a pharmaceutically acceptable salt thereof, as a once weekly subcutaneous dose selected from the group consisting of 20 mg and 25 mg tirzepatide, or a pharmaceutically acceptable salt thereof
Gut 51:842848